Xiaopeng Xu

Dr. Xiaopeng Xu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
XLXingyu Liao
Xingyu Liao
WZWufei Zhu
Wufei Zhu
JZJuexiao Zhou
Juexiao Zhou
HLHaoyang Li
Haoyang Li
XXXiaopeng Xu
Xiaopeng Xu
XGXin Gao
Xin Gao
Repetitive DNA sequences playing critical roles in driving evolution, inducing variation, and regulating gene expression. In this review, we summarized the definition, arrangement, and structural characteristics of repeats. Besides, we introduced diverse biological functions of repeats and reviewed existing methods for automatic repeat detection, classification, and masking. Finally, we analyzed the type, structure, and regulation of repeats in the human genome and their role in the induction of complex diseases. We believe that this review will facilitate a comprehensive understanding of repeats and provide guidance for repeat annotation and in-depth exploration of its association with human diseases.

19 December 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
JZJuexiao Zhou
Juexiao Zhou
LZLongxi Zhou
Longxi Zhou
DWDi Wang
Di Wang
XXXiaopeng Xu
Xiaopeng Xu
HLHaoyang Li
Haoyang Li
XGXin Gao
Xin Gao

24 June 2023 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
XXXiaopeng Xu
Xiaopeng Xu
TXTiantian Xu
Tiantian Xu
JZJuexiao Zhou
Juexiao Zhou
XLXingyu Liao
Xingyu Liao
RZRuochi Zhang
Ruochi Zhang
XGXin Gao
Xin Gao
Antibody leads must fulfill multiple desirable properties to be clinical candidates. Primarily due to the low throughput in the experimental procedure, the need for such multi-property optimization causes the bottleneck in preclinical antibody discovery and development, because addressing one issue usually causes another. We developed a reinforcement learning (RL) method, named AB-Gen, for antibody library design using a generative pre-trained transformer (GPT) as the policy network of the RL agent. We showed that this model can learn the antibody space of heavy chain complementarity determining region 3 (CDRH3) and generate sequences with similar property distributions. Besides, when using human epidermal growth factor receptor-2 (HER2) as the target, the agent model of AB-Gen was able to generate novel CDRH3 sequences that fulfill multi-property constraints. Totally, 509 generated sequences were able to pass all property filters, and three highly conserved residues were identified. The importance of these residues was further demonstrated by molecular dynamics simulations, consolidating that the agent model was capable of grasping important information in this complex optimization task. Overall, the AB-Gen method is able to design novel antibody sequences with an improved success rate than the traditional propose-then-filter approach. It has the potential to be used in practical antibody design, thus empowering the antibody discovery and development process. The source code of AB-Gen is freely available at Zenodo (https://doi.org/10.5281/zenodo.7657016) and BioCode (https://ngdc.cncb.ac.cn/biocode/tools/BT007341).

18 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHaoyang Li
Haoyang Li
YLYingxin Lin
Yingxin Lin
WHWenjia He
Wenjia He
WHWenkai Han
Wenkai Han
XXXiaopeng Xu
Xiaopeng Xu
XGXin Gao
Xin Gao
With the flourishing of spatial omics technologies, alignment and stitching of slices becomes indispensable to decipher a holistic view of 3D molecular profile. However, existing alignment and stitching methods are unpractical to process large-scale and image-based spatial omics dataset due to extreme time consumption and unsatisfactory accuracy. Here we propose SANTO, a coarse-to-fine method targeting alignment and stitching tasks for spatial omics. SANTO firstly rapidly supplies reasonable spatial positions of two slices and identifies the overlap region. Then, SANTO refines the positions of two slices by considering spatial and omics patterns. Comprehensive experiments demonstrate the superior performance of SANTO over existing methods. Specifically, SANTO stitches cross-platform slices for breast cancer samples, enabling integration of complementary features to synergistically explore tumor microenvironment. SANTO is then applied to 3D-to-3D spatiotemporal alignment to study development of mouse embryo. Furthermore, SANTO enables cross-modality alignment of spatial transcriptomic and epigenomic data to understand complementary interactions.


3 June 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XXXiaopeng Xu
Xiaopeng Xu
CXChencheng Xu
Chencheng Xu
WHWenjia He
Wenjia He
LWLesong Wei
Lesong Wei
HLHaoyang Li
Haoyang Li
XGXin Gao
Xin Gao
Macrocyclic peptides hold great promise as therapeutics targeting intracellular proteins. This stems from their remarkable ability to bind flat protein surfaces with high affinity and specificity while potentially traversing the cell membrane. Research has already explored their use in developing inhibitors for intracellular proteins, such as KRAS, a well-known driver in various cancers. However, computational approaches for de novo macrocyclic peptide design remain largely unexplored. Here, we introduce HELM-GPT, a novel method that combines the strength of the hierarchical editing language for macromolecules (HELM) representation and generative pre-trained transformer (GPT) for de novo macrocyclic peptide design. Through reinforcement learning (RL), our experiments demonstrate that HELM-GPT has the ability to generate valid macrocyclic peptides and optimize their properties. Furthermore, we introduce a contrastive preference loss during the RL process, further enhanced the optimization performance. Finally, to co-optimize peptide permeability and KRAS binding affinity, we propose a step-by-step optimization strategy, demonstrating its effectiveness in generating molecules fulfilling both criteria. In conclusion, the HELM-GPT method can be used to identify novel macrocyclic peptides to target intracellular proteins. The code and data of HELM-GPT are freely available on GitHub (https://github.com/charlesxu90/helm-gpt).